Skip to content
Disclosery

PharVision Advisers, LLC: ORC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of PharVision Advisers, LLC on ORC, newest first. How the timeline and the estimate are built.

PharVision Advisers, LLC held 0 ORC shares at 2026-06-30 per its 13F-HR filed 2026-08-11.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 0 shares
    Change vs previous 13F -18,180 shares

    13F-HR 0001420506-26-001505 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2026-03-31
    13F/A 18,180 shares
    Change vs previous 13F -31,357 shares

    1.3% of the 13F portfolio, value $127,805.

    13F-HR/A 0001420506-26-000909 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 49,537 shares
    Change vs previous 13F +15,812 shares

    0.18% of the 13F portfolio, value $356,666.

    13F-HR 0001420506-26-000567 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 33,725 shares
    Change vs previous 13F -13,770 shares

    0.13% of the 13F portfolio, value $236,412.

    13F-HR 0001420506-25-003453 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 47,495 shares
    Change vs previous 13F +26,647 shares

    0.48% of the 13F portfolio, value $332,940.

    13F-HR 0001420506-25-001926 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 20,848 shares
    Change vs previous 13F not available

    0.22% of the 13F portfolio, value $156,777.

    13F-HR 0001420506-25-001232 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).